Higher levels of inflammatory markers, including C-reactive protein (CRP) and the neutrophil-to-lymphocyte ratio, as well as various inflammatory cytokines and chemokines, have been shown to be related to a more severe clinical course in patients with COVID-19 [4,6]. This evidence concerns the gene CRP and COVID-19.